AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 33 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $349,000 | -12.3% | 147,800 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $398,000 | +50.8% | 147,800 | +64.2% | 0.01% | +66.7% |
| Q3 2018 | $264,000 | +98.5% | 90,000 | +80.0% | 0.00% | +200.0% |
| Q2 2018 | $133,000 | -81.1% | 50,000 | 0.0% | 0.00% | -87.5% |
| Q1 2018 | $704,000 | +19.7% | 50,000 | 0.0% | 0.01% | +33.3% |
| Q4 2017 | $588,000 | -17.2% | 50,000 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $710,000 | +0.9% | 50,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $704,000 | -15.7% | 50,000 | 0.0% | 0.01% | -20.0% |
| Q1 2017 | $835,000 | +1.1% | 50,000 | 0.0% | 0.01% | -9.1% |
| Q4 2016 | $826,000 | -0.2% | 50,000 | -19.4% | 0.01% | -8.3% |
| Q3 2016 | $828,000 | +102.0% | 62,000 | 0.0% | 0.01% | +100.0% |
| Q2 2016 | $410,000 | +286.8% | 62,000 | +416.7% | 0.01% | +200.0% |
| Q1 2016 | $106,000 | -43.3% | 12,000 | -20.0% | 0.00% | -33.3% |
| Q4 2015 | $187,000 | -11.4% | 15,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $211,000 | +102.9% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q2 2015 | $104,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 400,900 | $1,062,000 | 0.78% |
| EMORY UNIVERSITY | 209,207 | $554,000 | 0.37% |
| EcoR1 Capital, LLC | 1,150,000 | $3,048,000 | 0.29% |
| Baker Brothers Advisors | 10,934,154 | $28,976,000 | 0.22% |
| DLD Asset Management, LP | 763,100 | $2,030,000 | 0.15% |
| UNIVERSITY OF NOTRE DAME DU LAC | 214,759 | $569,000 | 0.11% |
| Kalos Management, Inc. | 15,850 | $226,000 | 0.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 257,613 | $683,000 | 0.09% |
| DLD Asset Management, LP | 379,900 | $1,007,000 | 0.08% |
| DLD Asset Management, LP | 379,300 | $1,009,000 | 0.08% |